Thermo Fisher Scientific Completes Acquisition of PPD, Inc.
Thermo Fisher's $12.5B deal for Qiagen falls through, as COVID-19 test demand lights new path forward | Fierce Biotech
Newsroom - Overview | Newsroom | Thermo Fisher Scientific
Qiagen Shares Jump as Thermo Fisher Is Said to Weigh Acquisition - Bloomberg
Thermo Fisher: Slowing Growth Suggests Acquisition-Heavy Company Is Overvalued (NYSE:TMO) | Seeking Alpha
Thermo Fisher Scientific: 14% Revenue Boost From PPD Acquisition
Thermo Fisher Scientific Folds on $12.5B Qiagen Deal | mddionline.com
Life Tech in $13.6 Billion Buyout by Thermo Fisher
Thermo Fisher Scientific announces $600M+ in capital investments to expand bioprocessing production capabilities – The Journal of Healthcare Contracting
Thermo Fisher closes $17.4 billion acquisition - Boston Business Journal
Thermo Fisher Scientific Mergers and Acquisitions Summary | Mergr
Thermo Fisher snaps up PPD in $17.4b acquisition deal
Thermo Fisher: Slowing Growth Suggests Acquisition-Heavy Company Is Overvalued (NYSE:TMO) | Seeking Alpha
Thermo Fisher Scientific Ponders Growth Options
Thermo Fisher Invests in Gene Therapy Future with Huge Expansions | BioSpace
What We Do | Thermo Fisher Scientific
Thermo Fisher Scientific Set to Acquire Qiagen for $11.5B | mddionline.com
Thermo Fisher Scientific targets M&A as COVID-19-related impact wanes (NYSE:TMO) | Seeking Alpha
Thermo Fisher Scientific Completes Acquisition of PPD, Inc.
Thermo Fisher nixes $12.7B Qiagen acquisition - Washington Business Journal
PPD Outlines New Risk Factors Amid Pending Thermo Fisher Merger | Nasdaq
Thermo Fisher Scientific Ponders Growth Options
Thermo Fisher: Slowing Growth Suggests Acquisition-Heavy Company Is Overvalued (NYSE:TMO) | Seeking Alpha
